FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Stem cell research & therapy2016; 7(1); 137; doi: 10.1186/s13287-016-0398-9

Evaluation of amniotic mesenchymal cell derivatives on cytokine production in equine alveolar macrophages: an in vitro approach to lung inflammation.

Abstract: Data obtained in both animal models and clinical trials suggest that cell-based therapies represent a potential therapeutic strategy for lung repair and remodeling. Recently, new therapeutic approaches based on the use of stem cell derivatives (e.g., conditioned medium (CM) and microvesicles (MVs)) to regenerate tissues and improve their functions were proposed. The aim of this study was to investigate the immunomodulatory effects of equine amniotic mesenchymal cell derivatives on lipopolysaccharide (LPS)-induced cytokine production in equine alveolar macrophages, which may be beneficial in lung inflammatory disorders such as recurrent airway obstruction (RAO) in horses. RAO shares many features with human asthma, including an increased number of cells expressing mRNA for interleukin (IL)-4 and IL-5 and a decreased expression of IFN-γ in bronchoalveolar lavage fluid (BALF) of affected horses. The release of TNF-α, IL-6, and TGF-β1 at different time points (1, 24, 48, and 72 h) was measured in equine alveolar macrophages stimulated or not with LPS (10 and 100 ng/mL) in the presence or absence of 10 % CM or 50 × 10(6) MVs/mL. Cytokines were measured using commercially available ELISA kits. For multiple comparisons, analysis of variance was used with Tukey post-hoc test. Differences were considered significant at p ≤ 0.05. Significant modulatory effects of CM on LPS-induced TNF-α release at 24 h, and of both CM and MVs on TNF-α release at 48 h were observed. A trend toward a modulatory effect of both CM and MVs on the release of TGF-β and possibly IL-6 was visible over time. Results support the potential use of CM and MVs in lung regenerative medicine, especially in situations in which TGF-β may be detrimental, such as respiratory allergy. Further studies should evaluate the potential clinical applications of CM and MVs in equine lung diseases, such as RAO and other inflammatory disorders.
Get Full Text
Publication Date: 2016-09-20 PubMed ID: 27651133PubMed Central: PMC5028987DOI: 10.1186/s13287-016-0398-9Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study investigates how stem cell derivatives from horse amniotic fluid can alter lung inflammation responses in horse lung cells. It is part of the effort to develop cell-based therapies for repairing lung damage and relieving inflammation in respiratory conditions like asthma.

Research Objective

The research sought to understand if and how derivatives of equine amniotic mesenchymal cells influence cytokine production in horse lung cells when these cells are exposed to lipopolysaccharide (LPS). By looking at the effects on the cytokines TNF-α, IL-6, and TGF-β1, the researchers hoped to gain insights regarding the potential use of these stem cell derivatives in treating lung inflammatory diseases, such as recurrent airway obstruction (RAO) in horses which shares many features with human asthma.

Methodology

  • The researchers used two types of cell derivatives: conditioned medium (CM) and microvesicles (MVs).
  • Their effect was studied in horse lung cells (equine alveolar macrophages) which were or weren’t exposed to LPS, an inflammation trigger.
  • Different LPS concentrations were used and the cells were also exposed to varying amounts of CM or MVs.
  • The release of TNF-α, IL-6, and TGF-β1 was measured at 1, 24, 48, and 72 hours intervals using ELISA kits, a standard tool for measuring proteins in samples.
  • Finally, statistical analysis was conducted to identify any significant differences in cytokine release, due to the various treatments.

Findings

  • The researchers noted that the CM treatment significantly reduced the LPS-induced release of TNF-α at the 24-hour and 48-hour intervals.
  • Both the CM and MVs treatments seemed to reduce the TNF-α release at the 48-hour point.
  • There was a suggestion that both treatments had a modulatory effect on the release of TGF-β and possibly also IL-6, but this needs further exploration.

Implications

The results support the idea that CM and MVs could have therapeutic value in lung pathology, especially in cases where reducing TGF-β could be beneficial, for instance, in respiratory allergies. While promising, these findings serve as preliminary data and the researchers stress the need for further studies to confirm these effects and explore their potential in clinical applications for equine lung diseases and other inflammatory disorders.

Cite This Article

APA
Zucca E, Corsini E, Galbiati V, Lange-Consiglio A, Ferrucci F. (2016). Evaluation of amniotic mesenchymal cell derivatives on cytokine production in equine alveolar macrophages: an in vitro approach to lung inflammation. Stem Cell Res Ther, 7(1), 137. https://doi.org/10.1186/s13287-016-0398-9

Publication

Stem cell research & therapy
ISSN: 1757-6512
NlmUniqueID: 101527581
Country: England
Language: English
Volume: 7
Issue: 1
Pages: 137
PII: 137

Researcher Affiliations

Zucca, Enrica
  • Department of Health, Animal Science and Food Safety (VESPA), Università degli Studi di Milano, Via Celoria 10, 20133, Milano, Italy.
Corsini, Emanuela
  • Laboratory of Toxicology, DiSFeB, Università degli Studi di Milano, Milan, Italy.
Galbiati, Valentina
  • Laboratory of Toxicology, DiSFeB, Università degli Studi di Milano, Milan, Italy.
Lange-Consiglio, Anna
  • Large Animal Hospital, Reproduction Unit, Università degli Studi di Milano, Lodi, Italy. anna.langeconsiglio@unimi.it.
Ferrucci, Francesco
  • Department of Health, Animal Science and Food Safety (VESPA), Università degli Studi di Milano, Via Celoria 10, 20133, Milano, Italy.

MeSH Terms

  • Amnion / cytology
  • Amnion / immunology
  • Amnion / metabolism
  • Animals
  • Cell-Derived Microparticles / chemistry
  • Cell-Derived Microparticles / immunology
  • Culture Media, Conditioned / chemistry
  • Culture Media, Conditioned / pharmacology
  • Female
  • Horse Diseases / immunology
  • Horse Diseases / pathology
  • Horses
  • Interleukin-6 / biosynthesis
  • Interleukin-6 / immunology
  • Lipopolysaccharides / pharmacology
  • Macrophages, Alveolar / cytology
  • Macrophages, Alveolar / drug effects
  • Macrophages, Alveolar / immunology
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / immunology
  • Mesenchymal Stem Cells / metabolism
  • Models, Biological
  • Pneumonia / immunology
  • Pneumonia / pathology
  • Pneumonia / veterinary
  • Primary Cell Culture
  • Transforming Growth Factor beta1 / biosynthesis
  • Transforming Growth Factor beta1 / immunology
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Tumor Necrosis Factor-alpha / immunology

References

This article includes 43 references
  1. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice.. J Immunol 2007 Aug 1;179(3):1855-63.
    doi: 10.4049/jimmunol.179.3.1855pubmed: 17641052google scholar: lookup
  2. Mei SH, McCarter SD, Deng Y, Parker CH, Liles WC, Stewart DJ. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1.. PLoS Med 2007 Sep;4(9):e269.
    doi: 10.1371/journal.pmed.0040269pmc: PMC1961632pubmed: 17803352google scholar: lookup
  3. Lee JW, Fang X, Gupta N, Serikov V, Matthay MA. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung.. Proc Natl Acad Sci U S A 2009 Sep 22;106(38):16357-62.
    doi: 10.1073/pnas.0907996106pmc: PMC2735560pubmed: 19721001google scholar: lookup
  4. Matthay MA, Thompson BT, Read EJ, McKenna DH Jr, Liu KD, Calfee CS, Lee JW. Therapeutic potential of mesenchymal stem cells for severe acute lung injury.. Chest 2010 Oct;138(4):965-72.
    doi: 10.1378/chest.10-0518pmc: PMC2951759pubmed: 20923800google scholar: lookup
  5. Sueblinvong V, Weiss DJ. Stem cells and cell therapy approaches in lung biology and diseases.. Transl Res 2010 Sep;156(3):188-205.
    doi: 10.1016/j.trsl.2010.06.007pmc: PMC4201367pubmed: 20801416google scholar: lookup
  6. Takahashi T, Lord B, Schulze PC, Fryer RM, Sarang SS, Gullans SR, Lee RT. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes.. Circulation 2003 Apr 15;107(14):1912-6.
    doi: 10.1161/01.CIR.0000064899.53876.A3pubmed: 12668514google scholar: lookup
  7. Wei JP, Zhang TS, Kawa S, Aizawa T, Ota M, Akaike T, Kato K, Konishi I, Nikaido T. Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice.. Cell Transplant 2003;12(5):545-52.
    doi: 10.3727/000000003108747000pubmed: 12953929google scholar: lookup
  8. Miki T, Strom SC. Amnion-derived pluripotent/multipotent stem cells.. Stem Cell Rev 2006;2(2):133-42.
    doi: 10.1007/s12015-006-0020-0pubmed: 17237552google scholar: lookup
  9. Toda A, Okabe M, Yoshida T, Nikaido T. The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues.. J Pharmacol Sci 2007 Nov;105(3):215-28.
    doi: 10.1254/jphs.CR0070034pubmed: 17986813google scholar: lookup
  10. Lange-Consiglio A, Corradetti B, Bizzaro D, Magatti M, Ressel L, Tassan S, Parolini O, Cremonesi F. Characterization and potential applications of progenitor-like cells isolated from horse amniotic membrane.. J Tissue Eng Regen Med 2012 Aug;6(8):622-35.
    doi: 10.1002/term.465pubmed: 21948689google scholar: lookup
  11. Lange-Consiglio A, Rossi D, Tassan S, Perego R, Cremonesi F, Parolini O. Conditioned medium from horse amniotic membrane-derived multipotent progenitor cells: immunomodulatory activity in vitro and first clinical application in tendon and ligament injuries in vivo.. Stem Cells Dev 2013 Nov 15;22(22):3015-24.
    doi: 10.1089/scd.2013.0214pubmed: 23795963google scholar: lookup
  12. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P, Ratajczak MZ. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery.. Leukemia 2006 May;20(5):847-56.
    doi: 10.1038/sj.leu.2404132pubmed: 16453000google scholar: lookup
  13. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L. Exosomes/microvesicles as a mechanism of cell-to-cell communication.. Kidney Int 2010 Nov;78(9):838-48.
    doi: 10.1038/ki.2010.278pubmed: 20703216google scholar: lookup
  14. Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses.. Nat Rev Immunol 2009 Aug;9(8):581-93.
    doi: 10.1038/nri2567pubmed: 19498381google scholar: lookup
  15. Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication.. J Proteomics 2010 Sep 10;73(10):1907-20.
    doi: 10.1016/j.jprot.2010.06.006pubmed: 20601276google scholar: lookup
  16. György B, Szabó TG, Pásztói M, Pál Z, Misják P, Aradi B, László V, Pállinger E, Pap E, Kittel A, Nagy G, Falus A, Buzás EI. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles.. Cell Mol Life Sci 2011 Aug;68(16):2667-88.
    doi: 10.1007/s00018-011-0689-3pmc: PMC3142546pubmed: 21560073google scholar: lookup
  17. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati B, Tetta C, Camussi G. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury.. J Am Soc Nephrol 2009 May;20(5):1053-67.
    doi: 10.1681/ASN.2008070798pmc: PMC2676194pubmed: 19389847google scholar: lookup
  18. Biancone L, Bruno S, Deregibus MC, Tetta C, Camussi G. Therapeutic potential of mesenchymal stem cell-derived microvesicles.. Nephrol Dial Transplant 2012 Aug;27(8):3037-42.
    doi: 10.1093/ndt/gfs168pubmed: 22851627google scholar: lookup
  19. Lange-Consiglio A, Perrini C, Tasquier R, Deregibus MC, Camussi G, Pascucci L, Marini MG, Corradetti B, Bizzaro D, De Vita B, Romele P, Parolini O, Cremonesi F. Equine Amniotic Microvesicles and Their Anti-Inflammatory Potential in a Tenocyte Model In Vitro.. Stem Cells Dev 2016 Apr 15;25(8):610-21.
    doi: 10.1089/scd.2015.0348pubmed: 26914245google scholar: lookup
  20. Bullone M, Lavoie JP. Asthma "of horses and men"--how can equine heaves help us better understand human asthma immunopathology and its functional consequences?. Mol Immunol 2015 Jul;66(1):97-105.
    doi: 10.1016/j.molimm.2014.12.005pubmed: 25547716google scholar: lookup
  21. Leclere M, Lavoie-Lamoureux A, Lavoie JP. Heaves, an asthma-like disease of horses.. Respirology 2011 Oct;16(7):1027-46.
    doi: 10.1111/j.1440-1843.2011.02033.xpubmed: 21824219google scholar: lookup
  22. Kaup FJ, Drommer W, Damsch S, Deegen E. Ultrastructural findings in horses with chronic obstructive pulmonary disease (COPD). II: Pathomorphological changes of the terminal airways and the alveolar region.. Equine Vet J 1990 Sep;22(5):349-55.
    doi: 10.1111/j.2042-3306.1990.tb04288.xpubmed: 2226400google scholar: lookup
  23. Molet S, Hamid Q. Role of airway remodeling in severe asthma.. 2001;p. 89–124.
  24. Berger M, de Boer D, Van der Sluijs K, Bresser P, van der Poll T, Lutter R, Sterk PJ, van der Zee J. Local and systemic inflammatory responses following low-dose bronchial endotoxin instillation in mild asthmatics.. Proc. Am. Thoracic Society International Conference My ATS 2011.
    doi: 10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2545google scholar: lookup
  25. Ferrucci F, Di Fabio V, Ferro E, Croci C. Cytologic classification of IAD/SAID according to bronchoalveolar lavage fluid findings in 70 racehorses presented for poor performance.. SISVet Ann Meet Select Abstr 2001;3(3):101–2.
  26. Ferro E, Ferrucci F, Zucca E, Di Fabio V, Castoldi S. Arterial blood gas analysis in 53 racehorses with a diagnosis of small airway inflammatory disease (SAID). J Equine Vet Sci 2002;22(1):165–8.
    doi: 10.1016/S0737-0806(02)70142-1google scholar: lookup
  27. Gerlier D, Thomasset N. Use of MTT colorimetric assay to measure cell activation.. J Immunol Methods 1986 Nov 20;94(1-2):57-63.
    doi: 10.1016/0022-1759(86)90215-2pubmed: 3782817google scholar: lookup
  28. Cossetti C, Iraci N, Mercer TR, Leonardi T, Alpi E, Drago D, Alfaro-Cervello C, Saini HK, Davis MP, Schaeffer J, Vega B, Stefanini M, Zhao C, Muller W, Garcia-Verdugo JM, Mathivanan S, Bachi A, Enright AJ, Mattick JS, Pluchino S. Extracellular vesicles from neural stem cells transfer IFN-γ via Ifngr1 to activate Stat1 signaling in target cells.. Mol Cell 2014 Oct 23;56(2):193-204.
    doi: 10.1016/j.molcel.2014.08.020pmc: PMC4578249pubmed: 25242146google scholar: lookup
  29. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends.. J Cell Biol 2013 Feb 18;200(4):373-83.
    doi: 10.1083/jcb.201211138pmc: PMC3575529pubmed: 23420871google scholar: lookup
  30. Bobrie A, Colombo M, Raposo G, Théry C. Exosome secretion: molecular mechanisms and roles in immune responses.. Traffic 2011 Dec;12(12):1659-68.
    doi: 10.1111/j.1600-0854.2011.01225.xpubmed: 21645191google scholar: lookup
  31. De Jong OG, Van Balkom BW, Schiffelers RM, Bouten CV, Verhaar MC. Extracellular vesicles: potential roles in regenerative medicine.. Front Immunol 2014;5:608.
    pmc: PMC4253973pubmed: 25520717doi: 10.3389/fimmu.2014.00608google scholar: lookup
  32. Fröhlich D, Kuo WP, Frühbeis C, Sun JJ, Zehendner CM, Luhmann HJ, Pinto S, Toedling J, Trotter J, Krämer-Albers EM. Multifaceted effects of oligodendroglial exosomes on neurons: impact on neuronal firing rate, signal transduction and gene regulation.. Philos Trans R Soc Lond B Biol Sci 2014 Sep 26;369(1652).
    pmc: PMC4142031pubmed: 25135971doi: 10.1098/rstb.2013.0510google scholar: lookup
  33. Wan YY, Flavell RA. 'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation.. Immunol Rev 2007 Dec;220:199-213.
    doi: 10.1111/j.1600-065X.2007.00565.xpmc: PMC2614905pubmed: 17979848google scholar: lookup
  34. Mills CD. Anatomy of a discovery: m1 and m2 macrophages.. Front Immunol 2015;6:212.
    pmc: PMC4419847pubmed: 25999950doi: 10.3389/fimmu.2015.00212google scholar: lookup
  35. Karagianni AE, Kapetanovic R, McGorum BC, Hume DA, Pirie SR. The equine alveolar macrophage: functional and phenotypic comparisons with peritoneal macrophages.. Vet Immunol Immunopathol 2013 Oct 1;155(4):219-28.
    doi: 10.1016/j.vetimm.2013.07.003pmc: PMC3795452pubmed: 23978307google scholar: lookup
  36. Karagianni AE, Kapetanovic R, Summers KM, McGorum BC, Hume DA, Pirie RS. Comparative transcriptome analysis of equine alveolar macrophages.. Equine Vet J 2017 May;49(3):375-382.
    pmc: PMC5412682pubmed: 27096353doi: 10.1111/evj.12584google scholar: lookup
  37. Jones CV, Williams TM, Walker KA, Dickinson H, Sakkal S, Rumballe BA, Little MH, Jenkin G, Ricardo SD. M2 macrophage polarisation is associated with alveolar formation during postnatal lung development.. Respir Res 2013 Apr 5;14(1):41.
    doi: 10.1186/1465-9921-14-41pmc: PMC3626876pubmed: 23560845google scholar: lookup
  38. Lømo J, Blomhoff HK, Beiske K, Stokke T, Smeland EB. TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes.. J Immunol 1995 Feb 15;154(4):1634-43.
    pubmed: 7836748
  39. Chaouchi N, Arvanitakis L, Auffredou MT, Blanchard DA, Vazquez A, Sharma S. Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines.. Oncogene 1995 Oct 19;11(8):1615-22.
    pubmed: 7478586
  40. Wahl SM, Orenstein JM, Chen W. TGF-beta influences the life and death decisions of T lymphocytes.. Cytokine Growth Factor Rev 2000 Mar-Jun;11(1-2):71-9.
    doi: 10.1016/S1359-6101(99)00030-1pubmed: 10708954google scholar: lookup
  41. Tran DQ. TGF-β: the sword, the wand, and the shield of FOXP3(+) regulatory T cells.. J Mol Cell Biol 2012 Feb;4(1):29-37.
    doi: 10.1093/jmcb/mjr033pubmed: 22158907google scholar: lookup
  42. Ramesh S, Wildey GM, Howe PH. Transforming growth factor beta (TGFbeta)-induced apoptosis: the rise & fall of Bim.. Cell Cycle 2009 Jan 1;8(1):11-7.
    doi: 10.4161/cc.8.1.7291pmc: PMC3191464pubmed: 19106608google scholar: lookup
  43. Li Y, Liu Y, Fu Y, Wei T, Le Guyader L, Gao G, Liu RS, Chang YZ, Chen C. The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways.. Biomaterials 2012 Jan;33(2):402-11.
    doi: 10.1016/j.biomaterials.2011.09.091pubmed: 22019121google scholar: lookup

Citations

This article has been cited 12 times.
  1. Alashkar Alhamwe B, Potaczek DP, Miethe S, Alhamdan F, Hintz L, Magomedov A, Garn H. Extracellular Vesicles and Asthma-More Than Just a Co-Existence. Int J Mol Sci 2021 May 7;22(9).
    doi: 10.3390/ijms22094984pubmed: 34067156google scholar: lookup
  2. Harman RM, Marx C, Van de Walle GR. Translational Animal Models Provide Insight Into Mesenchymal Stromal Cell (MSC) Secretome Therapy. Front Cell Dev Biol 2021;9:654885.
    doi: 10.3389/fcell.2021.654885pubmed: 33869217google scholar: lookup
  3. Cequier A, Sanz C, Rodellar C, Barrachina L. The Usefulness of Mesenchymal Stem Cells beyond the Musculoskeletal System in Horses. Animals (Basel) 2021 Mar 25;11(4).
    doi: 10.3390/ani11040931pubmed: 33805967google scholar: lookup
  4. Velloso Alvarez A, Boone LH, Pondugula SR, Caldwell F, Wooldridge AA. Effects of Autologous Conditioned Serum, Autologous Protein Solution, and Triamcinolone on Inflammatory and Catabolic Gene Expression in Equine Cartilage and Synovial Explants Treated With IL-1β in Co-culture. Front Vet Sci 2020;7:323.
    doi: 10.3389/fvets.2020.00323pubmed: 32671108google scholar: lookup
  5. Lange-Consiglio A, Romele P, Magatti M, Silini A, Idda A, Martino NA, Cremonesi F, Parolini O. Priming with inflammatory cytokines is not a prerequisite to increase immune-suppressive effects and responsiveness of equine amniotic mesenchymal stromal cells. Stem Cell Res Ther 2020 Mar 4;11(1):99.
    doi: 10.1186/s13287-020-01611-zpubmed: 32131892google scholar: lookup
  6. MacDonald ES, Barrett JG. The Potential of Mesenchymal Stem Cells to Treat Systemic Inflammation in Horses. Front Vet Sci 2019;6:507.
    doi: 10.3389/fvets.2019.00507pubmed: 32039250google scholar: lookup
  7. Lange-Consiglio A, Gusmara C, Manfredi E, Idda A, Soggiu A, Greco V, Bonizzi L, Cremonesi F, Zecconi A. Antimicrobial Effects of Conditioned Medium From Amniotic Progenitor Cells in vitro and in vivo: Toward Tissue Regenerative Therapies for Bovine Mastitis. Front Vet Sci 2019;6:443.
    doi: 10.3389/fvets.2019.00443pubmed: 31921904google scholar: lookup
  8. Miao Y, Chen Z, Li SC. Functional endoscopy techniques for tracking stem cell fate. Quant Imaging Med Surg 2019 Mar;9(3):510-520.
    doi: 10.21037/qims.2019.02.12pubmed: 31032197google scholar: lookup
  9. Gaspari G, Funghi F, Cantile C, Camillo F, Panzani D, Maltinti S, Fanelli D, Moroni R, Cremonesi F, Gagni P, Lange-Consiglio A. Amniotic Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles for Equine Chronic Degenerative Endometritis Treatment. Vet Med Sci 2026 Mar;12(2):e70685.
    doi: 10.1002/vms3.70685pubmed: 41641829google scholar: lookup
  10. Lv K, Gao J, Yang L, Yuan X. The role of mesenchymal stem cell‑derived exosomes in asthma (Review). Mol Med Rep 2025 Jun;31(6).
    doi: 10.3892/mmr.2025.13531pubmed: 40242981google scholar: lookup
  11. Egli P, Boone L, Huber L, Higgins C, Gaonkar PP, Arrington J, Naskou MC, Peroni J, Gordon J, Lascola KM. Pilot study characterizing a single pooled preparation of equine platelet lysate for nebulization in the horse. Front Vet Sci 2024;11:1488942.
    doi: 10.3389/fvets.2024.1488942pubmed: 39726585google scholar: lookup
  12. Lanci A, Iacono E, Merlo B. Therapeutic Application of Extracellular Vesicles Derived from Mesenchymal Stem Cells in Domestic Animals. Animals (Basel) 2024 Jul 24;14(15).
    doi: 10.3390/ani14152147pubmed: 39123673google scholar: lookup
Subscribe to our newsletter
Join 99,850 horse owners like you who receive our email updates on horse health and nutrition.